A breakthrough in biologic implants
We’re transforming reconstructive surgery
We are developing cartilage-derived technology that eliminates patient harvesting and has the potential for therapeutic benefit throughout the body.
Requires harvesting surgery, with high risk of resorption.
Inconsistent quality and up to 75% long-term resorption rate, with tendency to warp.
Highly prone to extrusion, migration and infection; rejected by US surgeons.
Time savings of up to 50% and no donor site complications
Porcine cartilage is an inexpensive and easily sourced by-product.
We remove cell material and preserve the extracellular matrix (ECM) that gives cartilage its strength and unique characteristics.
We crosslink the ECM to make it enzyme-resistant and long-lasting while retaining its biomechanical characteristics.
We sterilize the cartilage without degrading the sensitive glycoaminoglycans to ensure efficacy and prevent infection.
